Skip to main content

Loading market data...

ICLR

ICON Public Limited Company

NASDAQ • United states

$182.43

+$8.24

(+4.73%)

Source: Yahoo Finance · Quote time Oct 21, 2026 13:50 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

ICON Public Limited Company (ICLR)

Unavailable

Quotes may be delayed

$13.97B

Market Cap

77,093

Volume

Unavailable

P/E Ratio

Unavailable

Div Yield

ICON Public Limited Company Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: SOUTH COUNTY BUSINESS PARK, DUBLIN 18, L2
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

13 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in ICON Public Limited Company.

6 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in ICON Public Limited Company.

16 May 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in ICON Public Limited Company.

15 May 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in ICON Public Limited Company.

15 May 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in ICON Public Limited Company.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$928.39M

Total assets (USD)$16.40B

Total liabilities (USD)$7.02B

Shareholders' equity (USD)$9.38B

Long-term debt (USD)$2.11B

Debt due within a year (USD)$55.15M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$2.06B	$137.83M	$72.58M	$0.94	6-K · 30 Jul 2026
Q1 2026	$2.03B	$173.73M	$104.75M	$1.36	6-K · 23 Jun 2026
Q4 2025	$2.11B	$207.85M	−$110.14M	Unavailable	20-F · 27 May 2026
Q3 2025	$2.08B	−$222.91M	−$284.18M	−$3.67	6-K/A · 27 May 2026
Q2 2025	$2.04B	$230.94M	$203.52M	$2.56	6-K · 30 Jul 2026
Q1 2025	$2.02B	$226.97M	$160.81M	$1.99	6-K · 23 Jun 2026

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $188.25

3.2% upside potential

📈

Strong Buy

Unavailable

👍

Buy

6

⏸️

Hold

5

📉

Sell

0

11 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 13:51 UTC Targets range 165.00–220.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

17

Sep 2026

McCague Eugene Pacelli

Director

Option exercise

$125.74 per share

3,255 shares

17

Sep 2026

McCague Eugene Pacelli

Director

Open-market sale

$175.00 per share

3,255 shares

17

Sep 2026

Murphy Ronan Martin

Director

Option exercise

$125.74 per share

5,005 shares

17

Sep 2026

Murphy Ronan Martin

Director

Open-market sale

$175.00 per share

5,005 shares

16

Sep 2026

CLIMAX JOHN DR

Director

Option exercise

$125.74 per share

5,005 shares

16

Sep 2026

CLIMAX JOHN DR

Director

Open-market sale

$175.00 per share

5,005 shares

11

Aug 2026

Whitaker Anne Clem

Director

Open-market sale

$164.29 per share

841 shares

11

Aug 2026

O'Neill Julie

Director

Open-market sale

$164.29 per share

915 shares

11

Aug 2026

Murray Ciaran

Director

Open-market sale

$164.29 per share

2,677 shares

11

Aug 2026

Murphy Ronan Martin

Director

Open-market sale

$164.29 per share

841 shares

Top Shareholders

Artisan Partners Limited Partnership

8,636,406 shares

4.318% change

6/30/2026

Wellington Management Group Llp

5,320,054 shares

-10.028% change

6/30/2026

Fmr Llc

5,271,321 shares

26.289% change

6/30/2026

Invesco Ltd.

5,264,236 shares

35.716% change

6/30/2026

Harris Associates L P

4,468,146 shares

2.685% change

6/30/2026

Brave Warrior Advisors, Llc

3,153,308 shares

5.222% change

6/30/2026

Greenhaven Associates Inc

3,100,615 shares

54.844% change

6/30/2026

Principal Financial Group Inc

2,950,974 shares

-10.894% change

6/30/2026

Massachusetts Financial Services Co /Ma/

2,105,171 shares

-22.826% change

6/30/2026

Ruane, Cunniff & Goldfarb L.P.

2,048,087 shares

25.295% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 13:51 UTC· 16 hours ago

Research coverage and investment tools

ICON Public Limited Company (ICLR) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Biotechnology: Commercial Physical & Biological Resarch). Its last price was US$182.43 on 21 Oct 2026. That is 84% of the way from its 52-week low of US$66.57 to its 52-week high of US$203.91. Its market capitalisation was US$13.97 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$2.06B	$137.83M	$72.58M	$0.94	—	6.7%	$238.85M	6-K · 30 Jul 2026 (opens in a new tab)
Q1 2026	$2.03B	$173.73M	$104.75M	$1.36	—	8.5%	$136.24M	6-K · 23 Jun 2026 (opens in a new tab)
Q4 2025	$2.11B	$207.85M	−$110.14M	Unavailable	—	9.8%	$174.83M	20-F · 27 May 2026 (opens in a new tab)
Q3 2025	$2.08B R (restated)	−$222.91M R (restated)	−$284.18M R (restated)	−$3.67 R (restated)	—	-10.7%	$333.90M	6-K/A · 27 May 2026 (opens in a new tab)
Q2 2025	$2.04B R (restated)	$230.94M R (restated)	$203.52M R (restated)	$2.56 R (restated)	—	11.3%	$113.92M	6-K · 30 Jul 2026 (opens in a new tab)
Q1 2025	$2.02B R (restated)	$226.97M R (restated)	$160.81M R (restated)	$1.99 R (restated)	—	11.3%	$239.33M	6-K · 23 Jun 2026 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	7/29/2026	$2.35	$2.26	+4.0%
Mar 2026	6/23/2026	$2.22	$2.16	+2.8%
Dec 2025	5/27/2026	$2.21	Unavailable	—
Sep 2025	10/22/2025	$2.83	$3.14	-9.9%

Cash and equivalents: $928.39M
Total assets: $16.40B
Total liabilities: $7.02B
Shareholders' equity: $9.38B
Long-term debt: $2.11B
Debt due within a year: $55.15M

SCHEDULE 13G/A · 13 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in ICON Public Limited Company.
SCHEDULE 13G/A · 6 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in ICON Public Limited Company.
SCHEDULE 13G · 16 May 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in ICON Public Limited Company.
SCHEDULE 13G/A · 15 May 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in ICON Public Limited Company.
SCHEDULE 13G/A · 15 May 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in ICON Public Limited Company.

Insider	Date	Transaction	Shares	Average price	Filing
McCague Eugene Pacelli Director	17 Sep 2026	Option exercise (M)	+3,255	$125.74	Form 4 (opens in a new tab)
McCague Eugene Pacelli Director	17 Sep 2026	Open-market sale (S)	−3,255	$175.00	Form 4 (opens in a new tab)
Murphy Ronan Martin Director	17 Sep 2026	Option exercise (M)	+5,005	$125.74	Form 4 (opens in a new tab)
Murphy Ronan Martin Director	17 Sep 2026	Open-market sale (S)	−5,005	$175.00	Form 4 (opens in a new tab)
CLIMAX JOHN DR Director	16 Sep 2026	Option exercise (M)	+5,005	$125.74	Form 4 (opens in a new tab)
CLIMAX JOHN DR Director	16 Sep 2026	Open-market sale (S)	−5,005	$175.00	Form 4 (opens in a new tab)
Whitaker Anne Clem Director	11 Aug 2026	Open-market sale (S)	−841	$164.29	Form 4 (opens in a new tab)
O'Neill Julie Director	11 Aug 2026	Open-market sale (S)	−915	$164.29	Form 4 (opens in a new tab)
Murray Ciaran Director	11 Aug 2026	Open-market sale (S)	−2,677	$164.29	Form 4 (opens in a new tab)
Murphy Ronan Martin Director	11 Aug 2026	Open-market sale (S)	−841	$164.29	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Artisan Partners Limited Partnership	6/30/2026	8,636,406	4.318%
Wellington Management Group Llp	6/30/2026	5,320,054	-10.028%
Fmr Llc	6/30/2026	5,271,321	26.289%
Invesco Ltd.	6/30/2026	5,264,236	35.716%
Harris Associates L P	6/30/2026	4,468,146	2.685%
Brave Warrior Advisors, Llc	6/30/2026	3,153,308	5.222%
Greenhaven Associates Inc	6/30/2026	3,100,615	54.844%
Principal Financial Group Inc	6/30/2026	2,950,974	-10.894%
Massachusetts Financial Services Co /Ma/	6/30/2026	2,105,171	-22.826%
Ruane, Cunniff & Goldfarb L.P.	6/30/2026	2,048,087	25.295%

Previous close: 174.19 USD
Day range: 171.54 – 184.00 USD
52-week range: 66.57 – 203.91 USD
Volume: 77,093
Market cap: $13.97B
Average volume: 803,023
EPS (FY 2025, diluted): 2.90 USD
Shares outstanding: 76.57M
Beta (5Y monthly): 1.22

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 13:50 UTC· 16 hours ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:21 UTC· 11 minutes ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for ICLR yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.